Vivek Ramaswamy, though less renowned than Elon Musk, possesses a complex web of financial interests that could lead to significant conflicts as he influences federal spending decisions.
Ramaswamy's substantial holdings in biotechnology and support for changing the FDA's drug approval processes could enrich himself and his investors by accelerating product launches.
As he seeks to shape energy policy favoring fossil fuels, Ramaswamy could direct investments towards his oil-and-gas fund, leveraging government influence to boost returns.
If Ramaswamy advocates for cryptocurrency-friendly regulations, his new Bitcoin business could also see significant benefits, raising questions about potential conflicts of interest in his role.
Collection
[
|
...
]